Across TCGA pan-cancer cohorts, EEF1A1P29 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated EEF1A1P29 data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher EEF1A1P29 RNA is associated with better overall survival. In most high-consensus cancer types, elevated EEF1A1P29 expression acts as an unfavorable survival marker, although some lineages such as SKCM and THCA show a favorable association.
SKCM, LUSC, and THCA are the cancer types where EEF1A1P29 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.